Literature DB >> 12854136

Expression of survivin in human gastric carcinoma and gastric carcinoma model of rats.

Xiao-Dong Zhu1, Geng-Jin Lin, Li-Ping Qian, Zhong-Qing Chen.   

Abstract

AIM: To study the expression of survivin, an inhibitor of apoptosis protein, in human gastric carcinomas and gastric carcinoma models of rats.
METHODS: With the method of immunohistochemical staining, we studied the expression of survivin in 20 cases of chronic gastritis and 56 cases of gastric carcinomas. We used N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and high dose sodium-chloride diet to induce rat gastric carcinomas. Survivin expression was studied in glandular stomachs of normal rats, adenocarcinomas and tissues adjacent to the tumor, as well as in rats during the induction period.
RESULTS: Survivin was expressed in 27 of 56 (48.2 %) cases of human gastric carcinoma tissues and 1 of 20 (5 %) cases of chronic gastritis. It was found that the expression of survivin had no relation with the elements of age, tumor depth, tumor size, and disease stage, but was significantly related to histological type. The positive rate of survivin expression in cases of intestinal type was significantly higher than that in cases of diffuse type (P<0.05). In animal experiments, survivin expression in glandular stomachs of normal rats, of rats in middle induction period, in adenocarcinomas and tissues adjacent to tumor were 0, 40.0 %, 78.3 % and 38.9 %, respectively. Compared with the survivin expression in normal rats, the differences were significant.
CONCLUSION: These data imply that survivin plays an important role in the onset of gastric carcinoma and that high survivin expression is an early event of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854136      PMCID: PMC4615478          DOI: 10.3748/wjg.v9.i7.1435

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Early apoptosis in intestinal and diffuse gastric carcinomas.

Authors:  Hong-Ping Zhou; Xu Wang; Nan-Zheng Zhang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Expression of regulating apoptosis gene and apoptosis index in primary liver cancer.

Authors:  Hong-Yu Xu; You-Lin Yang; Xi-Li Guan; Guang Song; Ai-Min Jiang; Li-Jun Shi
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 3.  Is intestinal metaplasia of the stomach reversible?

Authors:  M M Walker
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.

Authors:  R A Olie; A P Simões-Wüst; B Baumann; S H Leech; D Fabbro; R A Stahel; U Zangemeister-Wittke
Journal:  Cancer Res       Date:  2000-06-01       Impact factor: 12.701

5.  Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions.

Authors:  Ming-Yao Wu; Ying-Rui Liang; Xian-Ying Wu; Chu-Xiang Zhuang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

6.  Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review.

Authors:  Si-Chun Ming
Journal:  Gastric Cancer       Date:  1998-12       Impact factor: 7.370

Review 7.  Gastric epithelial dysplasia and adenoma: historical review and histological criteria for grading.

Authors:  N S Goldstein; K J Lewin
Journal:  Hum Pathol       Date:  1997-02       Impact factor: 3.466

8.  Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions.

Authors:  L Chantalat; D A Skoufias; J P Kleman; B Jung; O Dideberg; R L Margolis
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

9.  Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways.

Authors:  Edward M Conway; Saskia Pollefeyt; Marta Steiner-Mosonyi; Wei Luo; Astrid Devriese; Florea Lupu; Francoise Bono; Nathalie Leducq; Frederique Dol; Paul Schaeffer; Désiré Collen; Jean-Marc Herbert
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

10.  Inhibition of melanoma tumor growth in vivo by survivin targeting.

Authors:  D Grossman; P J Kim; J S Schechner; D C Altieri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  12 in total

1.  Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation.

Authors:  Chao Zhang; Zhan-Kui Liu; Pei-Wu Yu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  Survivin antisense compound inhibits proliferation and promotes apoptosis in liver cancer cells.

Authors:  De-Jian Dai; Cai-De Lu; Ri-Yong Lai; Jun-Ming Guo; Hua Meng; Wei-Sheng Chen; Jun Gu
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

3.  Knockdown of survivin gene expression by RNAi induces apoptosis in human hepatocellular carcinoma cell line SMMC-7721.

Authors:  Sheng-Quan Cheng; Wen-Liang Wang; Wei Yan; Qing-Long Li; Li Wang; Wen-Yong Wang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis.

Authors:  Andreas Krieg; Billur Baseras; Monika Tomczak; Pablo Emilio Verde; Nikolas Hendrik Stoecklein; Wolfram Trudo Knoefel
Journal:  Mol Biol Rep       Date:  2013-08-15       Impact factor: 2.316

5.  Survivin expression in early hepatocellular carcinoma and post-treatment with anti-cancer drug under hypoxic culture condition.

Authors:  Satoshi Mamori; Tadashi Asakura; Kiyoshi Ohkawa; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

6.  Expression of survivin and its significance in colorectal cancer.

Authors:  Wei-Chang Chen; Qiang Liu; Jian-Xin Fu; Su-Ya Kang
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

7.  Downregulation of survivin by RNAi inhibits growth of human gastric carcinoma cells.

Authors:  Guo-Ying Miao; Qi-Ming Lu; Xiu-Lan Zhang
Journal:  World J Gastroenterol       Date:  2007-02-28       Impact factor: 5.742

8.  Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection.

Authors:  Zhen-Ning Wang; Hui-Mian Xu; Li Jiang; Xin Zhou; Chong Lu; Xue Zhang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

9.  Survivin expression induced by doxorubicin in cholangiocarcinoma.

Authors:  Qing Chang; Zheng-Ren Liu; Da-Yu Wang; Manoj Kumar; Yi-Bei Chen; Ren-Yi Qin
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

10.  DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters.

Authors:  Qi-lian Liang; Bi-rong Wang; Guo-hong Li
Journal:  J Zhejiang Univ Sci B       Date:  2009-09       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.